
Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.
Merck Begins Tender Offer to Acquire Imago BioSciences, Inc. RAHWAY, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside of the United States and Canada,…
Merck Begins Tender Offer to Acquire Imago BioSciences, Inc. RAHWAY, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside of the United States and Canada,…
GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets GSK plc (LSE/NYSE: GSK) and…
GSK announces new global headquarters in central London GSK plc (LSE/NYSE: GSK) announced that its new global headquarters will be in central London. The company…
Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) announced 10.4 month follow-up data from the…
Pfizer Declares First-Quarter 2023 Dividend NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) announced that its board of directors declared an increase in the quarterly cash…
Bristol Myers Squibb Announces Dividend Increase NEW YORK–(BUSINESS WIRE)– Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of…
Roche Alzheimer’s disease Cerebrospinal Fluid (CSF) assays receive FDA clearance, supporting more accurate and timely diagnosis Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that its…
Coronavirus (COVID-19) Update: FDA Authorizes Updated (Bivalent) COVID-19 Vaccines for Children Down to 6 Months of Age the U.S. Food and Drug Administration amended the…
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4 Bivalent COVID-19 Vaccine in Children Under 5 Years Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq:…
FDA Provides Update on External Evaluation to Strengthen Agency’s Human Foods Program In July, I commissioned an external evaluation of the U.S. Food and Drug…
Phase III trial demonstrated Jardiance® is the first SGLT2 inhibitor to show statistically significant reduction in blood sugar levels in children and adolescents with type 2…
Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease Pfizer Inc. (NYSE: PFE) and Clear Creek Bio, Inc. today announced a research…